Restricting Interactions With Industry to Promote Evidence-Based Prescribing

JAMA Internal Medicine - United States
doi 10.1001/jamainternmed.2014.1862
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Factors Associated With Non Evidence-Based Prescribing of Antipsychotics

Therapeutic Advances in Psychopharmacology
2014English

Evidence-Based Prescribing for Post-Traumatic Stress Disorder

British Journal of Psychiatry
MedicinePsychiatryMental Health
2020English

Using Patient Decision Aids to Promote Evidence-Based Decision Making

Evidence-Based Medicine
Medicine
2001English

Evidence-Based Narratives to Improve Recall of Opioid Prescribing Guidelines: A Randomized Experiment

Academic Emergency Medicine
MedicineEmergency Medicine
2014English

Evidence-Based Prescribing of Statins: A Developing World Perspective

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2006English

Barriers to Prescribing Cannabis‐based Medicines

Prescriber
Pharmacology
2019English

Generic Prescribing and the Drug Industry

BMJ
1982English

A Series of Evidence-Based Drug Therapy Letters Improved Prescribing Behaviour

Evidence-Based Medicine
Medicine
2005English

Tobacco Industry Use of Flavourings to Promote Smokeless Tobacco Products

Tobacco Control
EnvironmentalPublic HealthHealthOccupational Health
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy